Collaborations across clinical, academic, and industry.
-
University of Auckland
Home institution. School of Pharmacy in the Faculty of Medical and Health Sciences, and the linked-data infrastructure that underpins the wider research programme.
Collaboration
Substantive clinical-academic appointment. Teaching, research, and doctoral supervision in pharmacy practice, pharmacoepidemiology, and clinical AI.
What Translational Health Co provided
Innovation in AI deployment across teaching and research, and active advocacy for AI fluency and responsible AI use across the Faculty.
Visit University of Auckland → -
DIGIPREDICT
A translational asthma-prediction programme out of the University of Auckland, combining a smartphone application, a wearable alerting layer, and a doctoral validation study.
Collaboration
Co-investigator. Joined to design and build the patient-facing layers of the programme.
What Translational Health Co provided
Design and build input on the public website and other digital brand assets, alongside the patient-facing application and the data infrastructure that ties the predictions back to outcomes.
Visit DIGIPREDICT → -
Medicines Intelligence Group
A University of Auckland research group focused on real-world medicines use across the New Zealand health system.
Collaboration
AI implementation lead, and research-theme lead on inappropriate use of prescription medicines, currently focused on opioid and asthma-related treatments.
What Translational Health Co provided
AI-implementation leadership and active advocacy for novel use of AI in research workflows, alongside cohort design, analysis, and policy-facing communication.
Visit Medicines Intelligence Group → -
AstraZeneca
Global biopharmaceutical company. Three funded research grants in the respiratory area, awarded in 2025.
Collaboration
Research co-investigator across the funded portfolio.
What Translational Health Co provided
Surgical-data and pharmacoepidemiology expertise that opened the research-grant pathway, alongside translation framing for the funded studies.
-
GSK
Global biopharmaceutical company. Hepatology engagement.
Collaboration
Consulting on strategic positioning and clinical translation in hepatology.
What Translational Health Co provided
Input on patient-facing resources, strategic positioning of therapy in the New Zealand market, and clinical expertise across the engagement.
-
Takeda
Global biopharmaceutical company. Inflammatory bowel disease engagement.
Collaboration
Consulting on market access and clinical positioning in inflammatory bowel disease.
What Translational Health Co provided
Market-access strategy, clinical-expertise input, and network development that introduced the team to key clinical and academic players in the field.